Lee H. Lytton, III

Professor Lee Lytton graduated from St. Mary’s Law School (San Antonio, TX) with High Honors in 1968. Following graduation, he served as briefing attorney to the late Judge K.K. Woodley, Presiding Judge of the Texas Court of Criminal Appeals. He was a Special Agent for the Federal Bureau of Investigation, subsequently joining the St. Mary’s law faculty at the behest of Dean James N. Castleberry in January 1987. He has published a book on Texas Real Property Law and he has served as a member of the Institutional Review Board of Southwest Methodist Hospital in San Antonio; and he is a ten year member of the Board of Directors of Fairway Medical Technologies, Inc.

William McLucas is currently President of Medical Center laboratory LLP II, Houston Texas. (MCL). MCL is a provider of full service clinical laboratories to all aspects of the Houston medical community. From November 1, 2003 to January 15, 2006 he was President of mergers and acquisitions for Clinical Labs USA, of Houston Texas (CLUSA). This company is a full service medical laboratory providing work to the long term care industry. The company was conceived and developed by a group of lab owners and an investment banki^l g group. It became one of the largest privately held laboratories in the southwest.  From June, 1986 to November, 2003 he was President and CEO of Alliance Clinical Laboratories. This company was built and started in Houston Texas. At the time of its merger with Clinical labs USA, it had offices in six cities, three hundred workers and sales in excess of twelve million dollars.  Beginning in January, 1983 throughout June 1986 Mr. McLucas was Founder and President of National Medical Financial Services (NMFS). NMFS was a home healthcare company that specialized in the sale of durable medical equipment. The company sales included the sale of all types of home use walkers, wheelchairs, hospital beds and home use medical needs. The company was also a provider of continuous use oxygen for people with respiratory failure. NMFS was sold to a public company in 1986.  Mr. McLucas developed a program for veterinary laboratory service for clinics throughout the country. Based in Houston, it serviced over twenty five hundred veterinarians from our Lab. With sales of over four million dollars the lab was sold to Vet Centers of America, a public company.

D. Bradley McWilliams

Mr. D. Bradley McWilliams, a Certified Public Accountant and Attorney at Law received his BBA and JD requires at the University of Texas (Austin). He did post graduate work at New York University and Harvard University. He spent 32 Years with Cooper Industries LTD, (CBE – NYSE), and retired as their chief Financial officer in 2003, after 32 years of service Mr. McWilliams has served on many corporate boards both for profit and non-profit boards, he is a life member of the Board of the YMCA of the Greater Houston area Inc. (which includes 42 branches in the greater Houston area) and he recently joined the University of Texas Health Science Center at Houston (UT- Houston) development board. Mr. McWilliams currently serve as a Board member, chairman of the Audit committee and a member of the Finance committee of McDermott International Inc. (MDR – NYSE); Mr. McWilliams is a major shareholder and
member of The Board of Directors of Fairway Medical Technologies Inc.

Morteza Naghavi, M.D.

Dr. Naghavi is an innovative medical doctor and researcher with interests in preventive cardiology, medical technology, and home healthcare. He graduated as a M.D. from Tehran University and was trained as a cardiovascular physician scientist under distinguished cardiologists Dr. S. Ward Casscells III and Dr. James T. Willerson at the Texas Heart Institute and the University of Texas Health Science Center in Houston. Dr. Naghavi is internationally recognized as a leader in heart attack prevention initiatives. Through his years of efforts in advancing the field of preventive cardiology, Dr. Naghavi founded the Society for Heart Attack Prevention and Eradication (SHAPE) and is the Executive Chairman of the SHAPE Task Force, an international non-profit coalition to overhaul the traditional (ineffective) methods of identifying individuals at risk of a near future heart attack. In 2009, the SHAPE organization helped pass Texas legislation HB1290 as the first heart attack preventive screening law in the United States. Dr. Naghavi has a number of collaborative academic research projects including NIH and NSF funded studies. He has numerous publications in scientific journals, most notably two major consensus statements (Part I and Part II) and the SHAPE Guidelines. He is also the editor of “Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment”, the most comprehensive textbook on risk assessment of the Vulnerable Patient. Along with academic activities, Dr. Naghavi is also an inventor and entrepreneur with over 30 patents and 5 companies one of which is listed on NASDAQ: VOLC. He is currently the President and CEO of Fairway Medical Technologies and IN3 Ventures. Dr. Naghavi is passionate about transforming new ideas into healthcare solutions, and welcomes innovative proposals from physicians, engineers, and entrepreneurs.

Ken Walz

Kenneth G. Walz a partner and co-founder of Popper and Company has spent more than 19 years in the biotech and medical device industries in business development and finance roles and has broad experience in the structuring and negotiation of collaborative arrangements, strategy development, and financial planning and analysis. At Popper and Company he assists early stage companies in all aspects of financial planning, capital raising, and business development including deal structuring and negotiation. Prior to co-founding Popper and Company, Mr. Walz was employed as VP Commercial Development at MDS Proteomics where he led the negotiation of a $50 million research collaboration with a leading biopharmaceutical company focused on discovery of therapeutics to treat diseases of the central nervous system. Previously, he managed business planning and analysis for BDGene, a unit of Becton Dickinson & Company. While at BDGene, he played a lead role in the evaluation of alliance candidates, creation of a business development strategy, deal valuation and structuring, and negotiation and closing of agreements. Mr. Walz earned a Master’s of Science in Finance from Loyola College of Maryland and a Bachelor of Arts in Economics from the University of Maryland.

Leo Womack

Leo B. Womack, has been the President and a director of Gulf Equities Realty Advisors, Inc., a diversified real estate portfolio management company, since 1986. He has been and continues to serve as the Executive Chairman of Fairway Medical Technologies, Inc., a medical device commercialization company and a portfolio company of the Baylor College of Medicine Venture Fund since 1996. From 1969 to 1978, Mr. Womack was the managing partner of a local and later national CPA firm. He has served on the Board of several public companies and is a past president and Chairman of the Houston Angel Network. Mr. Womack is licensed as a certified public accountant, and as a real estate broker. He is also an active member of NACD the National Association of Corporate Directors.